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Figure 1. Serum concentrations of CILP (a) and COMP (b) over a 5 year
period in ACL injury groups (grey) and in reference group (white). Boxes
deﬁne group median with 25th-75th percentile and whiskers 10th-90th
percentile error bars. Circles represent individual outliers. Signiﬁcance
(***, p<0.001) compared to references.
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Purpose: Sclerostin (SOST) – a negative regulator of the Wnt pathway –
expression has been detected in rodent and human chondrocytes.
Recent studies have suggested that changes in the activity of this
pathway can occur in osteoarthritis (OA) and that there may an asso-
ciation with periostin (POSTN), a protein involved in bone and joint
metabolism, especially related to mechanical stress. We have already
shown that POSTN is associatedwith knee OA. The aim of this study was
to investigate the relationships between serum SOST and prevalent OA
and progression of Kellgren-Lawrence (KL) score in women, along with
serum POSTN.
Subjects and Methods: We have investigated 585 women (mean age:
61.8  10.3 yrs) from the OFELY (Os des Femmes de Lyon) cohort, 19.7%
being premenopausal. Knee radiographs were performed at the ninth
annual follow-up (baseline for this analysis) and 4 years later and
scored using the KL classiﬁcation. Progression of joint destruction was
deﬁned as an increase of KL score  1 during the 4 years follow-up.
Serum SOST and serum POSTN were measured at baseline by ELISA
(TECOmedical, Sclerostin EIA kit, CH and USCN Life Science, Periostin
ELISA kit, China respectively).
Results: Serum SOST was signiﬁcantly associated with age only in
premenopausal women (n ¼ 115, r ¼ 0.27, p ¼ 0.004) and not sig-
niﬁcantly associated with serum POSTN (p ¼ 0.14). In addition, baseline
serum SOST levels were not statistically different between the 83
women with a KL score  2 at baseline compared to the 502 controls
with a KL score < 2 (0.65  0.17 ng/ml vs 0.69  0.21 ng/ml, p ¼ 0.36)
after adjustment for age. During the 4 year follow-up, 81 women had a
radiological progression in their knee KL score. Baseline SOST levels
were not signiﬁcantly different between progressors and non pro-
gressors (0.65  0.18 ng/ml vs 0.66  0.18 ng/ml, p ¼ 0.79) after
adjustment for age.
Conclusions: We found no signiﬁcant association between SOST and
prevalent knee OA as well as KL score progression. This is consistent
with observations made in a rat model.
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Purpose: Knee trauma induces joint cartilage degradation and plays an
important role in the development of osteoarthritis (OA). Our study
aimed to explore the serum levels of the cartilage biomarkers Cartilage
Intermediate Layer Protein (CILP) and Cartilage Oligomeric Matrix
Protein (COMP) over 5 years in the longitudinal randomized control
study (KANON), initiated to investigate structured rehabilitation of
anterior crucial ligament (ACL) injuries with or without surgical
reconstruction.
Methods: Blood samples were obtained at baseline (0-6 weeks after
injury), 3, 6, 12, 24 and 60 months after injury) from 121 subjects (26%
women, mean age of 26 years, range 18-36 years) with an acute ACL
rupture to a previously un-injured knee. Reference samples were
obtained from 21 age-matched knee-healthy individuals. Serum con-
centrations of the biomarkers were measured with a commercially
available sandwich COMP ELISA (AnaMar AB) and an in-house research
competitive immunoassay for CILP (AnaMar AB), where a 60 amino acid
long synthetic peptide (C-terminal part of CILP domain 1) was used as
coat and a peroxidase-conjugated polyclonal goat anti-CILP was used
for detection. Mann-Whitney rank sum test was used to compare COMP
and CILP concentrations at different time points between injured andknee-healthy subjects, and Spearman’s rank order correlation (rS) for
assessment of correlation.
Results: Despite variation in the concentration of serum CILP in indi-
vidual ACL patients over time, the median serum concentrations at the
cohort level were stable over the 5-year period, although the CILP level
was signiﬁcantly increased compared to knee-healthy subjects at all
time points (Figure 1a). The median serum concentration of COMP in
ACL patients showed no signiﬁcant difference compared to the refer-
ence group, and themedian concentration showed only small variations
over time. However, at each time point after baseline anumber of
patients showed higher serum COMP levels than any of the knee-
healthy subjects though no signiﬁcant difference was observed when
comparing the entire populations (Figure 1b). There was no correlation
between CILP and COMP values at the different time points after injury,
although a negative correlation (rS ¼ -0.202, p ¼ 0.0264) was found for
the entire 5-year time period.
Conclusions: This is the ﬁrst time that data are presented for the two
serum biomarkers CILP and COMP in a longitudinal cohort of patients
having an acute ACL rupture. Serum CILP stays elevated compared to
the knee-healthy subjects over the ﬁrst 5 years after ACL injury,
whereas no signiﬁcant differences could be seen at the population
level in serum COMP. Further evaluation, possibly linking biomarker
data to MR imaging ﬁndings, may shed light on the cartilage matrix
remodeling pathways after knee trauma leading to cartilage destruc-
tion and OA.
